Inventor · disambiguated record
David M. Bresse
Also filed as: BRESSE DAVID M
20 granted patents·6 pending applications·15 citations·filing 2013–2023
91Inventor score
Top patents by PatentIndex Score
26 records- 0191US9440916B23, 4-bis-benzylsulfonylbutyronitrile and its pharmaceutical useOLATEC THERAPEUTICS LLC·Filed 2016·Granted Sep 13, 2016·3 cites·9 claims
- 0289US9999610B2Pharmaceutical use of 3-benzylsulfonylpropionitrileOLATEC THERAPEUTICS LLC·Filed 2016·Granted Jun 19, 2018·3 cites·3 claims
- 0386US9474734B2Compounds for treating inflammation and painOLATEC IND LLC·Filed 2015·Granted Oct 25, 2016·2 cites·8 claims
- 0481US9114122B2Compounds for treating inflammation and painOLATEC IND LLC·Filed 2014·Granted Aug 25, 2015·1 cites·8 claims
- 0580US9522878B24-methylsulfonyl-2-butenenitrile and its pharmaceutical useOLATEC THERAPEUTICS LLC·Filed 2016·Granted Dec 20, 2016·1 cites·9 claims
- 0680US9481644B2Pharmaceutical composition comprising omega-(arylsulfonyl)alkylnitrileOLATEC IND LLC·Filed 2014·Granted Nov 1, 2016·1 cites·10 claims
- 0780US2023372279A1Pharmaceutical composition for treating inflammation and painOLATEC THERAPEUTICS LLC·Filed 2023·Application pending·0 cites
- 0879US8802885B2Process for preparing 3-methylsulfonylpropionitrileOLATEC IND LLC·Filed 2013·Granted Aug 12, 2014·1 cites·10 claims
- 0977US9205067B2Compounds for treating inflammation and painOLATEC IND LLC·Filed 2014·Granted Dec 8, 2015·2 cites·25 claims
- 1071US9149488B2Pharmaceutical composition and use of diethyl (2-cyanoethyl)phosphonateOLATEC IND LLC·Filed 2014·Granted Oct 6, 2015·1 cites·15 claims
- 1169US9024056B2Crystalline form of 3-methylsulfonylpropionitrileOLATEC IND LLC·Filed 2014·Granted May 5, 2015·0 cites·9 claims
- 1269US2021059971A1Pharmaceutical composition for treating inflammation and painOLATEC THERAPEUTICS LLC·Filed 2020·Application pending·0 cites
- 1368US10172822B2Pharmaceutical use of 3-benzylsulfonylpropionitrileOLATEC THERAPEUTICS LLC·Filed 2018·Granted Jan 8, 2019·0 cites·16 claims
- 1466US10143675B2Pharmaceutical composition for treating inflammation and painOLATEC THERAPEUTICS LLC·Filed 2016·Granted Dec 4, 2018·0 cites·7 claims
- 1565US9750714B2Pharmaceutical use of 3, 4-bis-benzylsulfonylbutyronitrileOLATEC THERAPEUTICS LLC·Filed 2016·Granted Sep 5, 2017·0 cites·12 claims
- 1664US9889111B2Pharmaceutical composition comprising omega-(arylsulfonyl)alkylnitrileOLATEC THERAPEUTICS LLC·Filed 2016·Granted Feb 13, 2018·0 cites·10 claims
- 1763US10751316B2Pharmaceutical composition for treating inflammation and painOLATEC THERAPEUTICS LLC·Filed 2017·Granted Aug 25, 2020·0 cites·6 claims
- 1863US9770429B24-methylsulfonyl-2-butenenitrile and its pharmaceutical useOLATEC THERAPEUTICS LLC·Filed 2016·Granted Sep 26, 2017·0 cites·6 claims
- 1963US9763909B2Methods for treating inflammation and painOLATEC THERAPEUTICS LLC·Filed 2016·Granted Sep 19, 2017·0 cites·5 claims
- 2063US9399620B2Process for preparing 3-methylsulfonylpropionitrileOLATEC IND LLC·Filed 2015·Granted Jul 26, 2016·0 cites·6 claims
- 2159US2013324603A1Pharmaceutical composition for treating inflammation and painOLATEC IND LLC·Filed 2013·Application pending·0 cites
- 2258US10441555B2Pharmaceutical compositionOLATEC THERAPEUTICS LLC·Filed 2016·Granted Oct 15, 2019·0 cites·10 claims
- 2351US2015182488A1Methods for treating inflammation and painOLATEC IND LLC·Filed 2015·Application pending·0 cites
- 2447US9987246B24-benzylsulfonyl-2-butenenitrileOLATEC THERAPEUTICS LLC·Filed 2016·Granted Jun 5, 2018·0 cites·14 claims
- 2543US2013324601A1Pharmaceutical composition for treating inflammation and painOLATEC IND LLC·Filed 2013·Application pending·0 cites
- 2642US2016158252A1Pharmaceutical composition and use of diethyl (2-cyanoethyl)phosphonateOLATEC THERAPEUTICS LLC·Filed 2016·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →